Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Post-market prevalence studies have found that Selective Serotonin Reuptake Inhibitor (SSRI) and Serotonin- Norepinephrine Reuptake Inhibitor (SNRI) sexual side effects occur at dramatically higher rates than initially reported in pre-market trials. Prescribing and practice conventions rest on the untested assumption that individuals who develop sexual dysfunction secondary to SSRI and SNRI antidepressant medications return fully to their pre-medication sexual functioning baseline shortly after discontinuing treatment. Most individuals probably do return to their previous level of sexual functioning, however recent case reports, consumer-provided Internet-based information, incidental research findings, and empirical evidence of persistent post SSRI sexual benefits in the premature ejaculation literature suggest that for some individuals, SSRI and SNRI-emergent sexual side effects persist indefinitely after discontinuing the medications. The literature poorly captures the full spectrum of SSRI/SNRI sexual side effects, and a lack of systematic follow-up in the sexual side effects research precludes detection of post SSRI/SNRI sexual dysfunction, leaving the formal knowledge base inadequate and even inaccurate, raising informed consent issues, and leaving clinicians vulnerable to practicing in ways that may be hurtful to patients in spite of their best efforts to inform themselves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Controlled discontinuation studies [111, 113, 114] showed that rebound may occur following SSRI discontinuation.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Severity varies according to the SSRI, paroxetine being the most likely to be associated with severe depressive and somatic symptoms, and fluoxetine being the least likely to be associated with severe depressive and somatic symptoms [5, 111].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A bulk of literature, derived from controlled trials [18, 110, 111], case reports [19], and patients' online reports [112], showed that new withdrawal symptoms may occur with any type of SSRI, but paroxetine is the most likely to be associated with new symptoms, while fluoxetine being the least associated.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In both studies [111, 113], patients treated with paroxetine had acute return of pre-treatment symptoms [10, 111, 113], while patients taking fluoxetine did not.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In one of the studies [111], patients taking paroxetine or sertraline had a sudden worsening of depressive symptoms upon drug discontinuation with a return to pre-placebo measurements following re-institution of the drug.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155 · cited 3×
“And neither unambiguously captures pleasureless orgasm or ejaculatory anhedonia; the CSFQ fails to do so by scoring decreased orgasmic intensity together with items assessing timing and frequency of orgasm, and the ASEX because the inquiry regarding changes in satisfaction from orgasm is less specific than changes in…”
InfluentialBulger, R. E. (1992) · Kennedy Institute of Ethics Journal · doi:10.1353/ken.0.0102 · Cited by 992
Professional Psychology: Research and Practice
Roberts, M. C., & Canter, K. S. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp256 · Cited by 754
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · cited 4×
“…take medication adjunctively to psychotherapy [2], and that one in eight adult American has *Address correspondence to this author at the University Counseling Service, 3223 Westlawn S., The University of Iowa, Iowa City, Iowa 52242- 1100, USA; Tel: 319 335-7294; Fax: 319 335-7298; E-mail:…”
BackgroundInfluentialDisorders of Orgasm and Ejaculation in Men
Rowland, D., McMahon, C. G., Abdo, C., Chen, J., Jannini, E., Waldinger, M. D., & Ahn, T. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01782.x · Cited by 508 · cited 1×
“Decreased orgasmic intensity or ejaculatory anhedonia are not mentioned in recent reviews of disorders of ejaculation and orgasm in men [38], or in women [39], and SSRI/SNRI-related decreased genital sensitivity or genital anesthesia, when mentioned, are reported to be uncommon [6, 14, 15].”
BackgroundMontejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505 · cited 3×
“Sexual side effects are known to occur as a result of drug treatment, but their prevalence is underestimated in the product literature, and the research literature poorly captures the quality and scope of the sexual side effects and how distressing they may be to patients.”
BackgroundMontejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460
The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.
Clayton, A. H., McGarvey, E. L., & Clavet, G. J. (1997) · PubMed · Cited by 358
Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry
Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C. S., & Paul, I. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300823 · Cited by 302 · cited 1×
“The patient maintained the conviction that his symptoms were a result of his past medication use, and declined the offer of a course of psychodynamic psychotherapy.”
BackgroundMeston, C. M., Hull, E., Levin, R. J., & Sipski, M. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10110.x · Cited by 267 · cited 1×
“…rates of a variety of sexual side effects; determining strategies for managing the sexual side effects: demonstrating the efficacy of one medication to serve as an antidote to the sexual dysfunction caused by another; and also on the ejaculationdelaying benefits of the various SSRIs when used as…”
BackgroundDisorders of Orgasm and Ejaculation in Men
McMahon, C. G., Abdo, C., Incrocci, L., Perelman, M., Rowland, D., Waldinger, M., & Xin, Z. C. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10109.x · Cited by 260
Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
Jacobsen, F. M. (1992) · PubMed · Cited by 236
Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
Fontanarosa, P. B. (2004) · JAMA · doi:10.1001/jama.292.21.2647 · Cited by 221
Nurnberg, H. G., Hensley, P. L., Gelenberg, A. J., Fava, M., Lauriello, J., & Paine, S. (2003) · JAMA · doi:10.1001/jama.289.1.56 · Cited by 212
Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205 · cited 1×
“Given mental health professionals’ responsibility for client welfare, when clients are taking or are contemplating taking SSRIs/SNRIs, psychologists have an obligation to inform clients of the possibility of sexual side effects, and in collaboration with clients and prescribing professionals, to…”
BackgroundPremature Ejaculation: Definition and Drug Treatment
Waldinger, M. D. (2007) · Drugs · doi:10.2165/00003495-200767040-00005 · Cited by 194
Prevalence of Premature Ejaculation: A Global and Regional Perspective
Montorsi, F. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.20369.x · Cited by 167 · cited 1×
“The well-established ejaculation-delaying effects of all of the SSRIs has led to their ubiquitous off-label use as a treatment for premature ejaculation (PE), and motivated industry to seek approval of SSRIs for a new indication reported to affect approximately 30% of men globally across all age groups [44] and to aff…”
BackgroundSSRI-Associated Sexual Dysfunction
Balon, R. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1504 · Cited by 166 · cited 3×
“Increasingly, they are prescribed off-label [1] to treat conditions such as peri-menopausal and post-menopausal hot flashes, chronic fatigue syndrome, chronic pain syndromes, premature ejaculation, and paraphilias.”
BackgroundMajor depressive disorder, antidepressants, and sexual dysfunction.
Clayton, A. H., & Montejo, A. L. (2006) · PubMed · Cited by 133
Persistent Sexual Dysfunction after Discontinuation of Selective Serotonin Reuptake Inhibitors
Csoka, A., Bahrick, A., & Mehtonen, O.-P. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00630.x · Cited by 131 · cited 4×
“However, post SSRI persistence of biological changes or adaptations can by no means be ruled out [ 8 ], are supported by animal studies [50-52], and thus ought to be a cause for”
BackgroundInfluentialSelf-citationBurden of phase-specific sexual dysfunction with SSRIs☆
Clayton, A. H., KELLER, A., & McGarvey, E. L. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.007 · Cited by 114 · cited 1×
“The Internet has proven to be a powerful tool for providing just such a database.”
MethodHsu, J. H., & Shen, W. W. (1995) · The International Journal of Psychiatry in Medicine · doi:10.2190/1dhu-y7l7-9gkg-v7wv · Cited by 110 · cited 1×
“He calls for careful attention to any real-time, emerging, alternative database of unexpected adverse drug events.”
BackgroundAntidepressant-Associated Changes in Semen Parameters
Tanrikut, C., & Schlegel, P. N. (2007) · Urology · doi:10.1016/j.urology.2006.10.034 · Cited by 109 · cited 1×
“Evidence presented comes from a variety of sources including incidental research findings, empirical findings, case reports, and consumer-reported experiences.”
BackgroundFerguson, J. M., Shrivastava, R. K., Stahl, S. M., Hartford, J. T., Borian, F., Ieni, J., McQuade, R. D., & Jody, D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0106 · Cited by 108 · cited 1×
“He again experienced penile anesthesia after several days on citalopram, which again resolved several days after stopping the medication.”
BackgroundChen, H., Reeves, J. H., Fincham, J. E., Kennedy, W. K., Dorfman, J. H., & Martin, B. C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0615 · Cited by 100 · cited 1×
“Increasingly, they are prescribed off-label [ 1 ] to treat conditions such as peri-menopausal and post-menopausal hot flashes, chronic fatigue syndrome, chronic pain syndromes, premature ejaculation, and paraphilias.”
BackgroundZajecka, J., Mitchell, S., & FAWCETT, J. A. (1997) · PubMed · Cited by 93
Influence of Physicians' Attitudes on Reporting Adverse Drug Events: A Case-Control Study
Figueiras, A., Tato, F., Fontaiñas, J., & Gestal, J. J. (1999) · Medical Care · doi:10.1097/00005650-199908000-00010 · Cited by 92
Persistent Sexual Side Effects after SSRI Discontinuation
Csoka, A. B., & Shipko, S. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091777 · Cited by 92
de Jong, T. R., Snaphaan, L. J. A. E., Pattij, T., Veening, J. G., Waldinger, M. D., Cools, A. R., & Olivier, B. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.06.004 · Cited by 71 · cited 1×
“However, post SSRI persistence of biological changes or adaptations can by no means be ruled out [8], are supported by animal studies [50-52], and thus ought to be a cause for concern.”
BackgroundSafarinejad, M. R., & Hosseini, S. Y. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901384 · Cited by 68 · cited 7×
“Two recent studies found robust evidence for sustained post-treatment effects of SSRIs on ejaculation latency [ 12 , 13].”
BackgroundResultInfluentialTreatment of premature ejaculation with sertraline hydrochloride
McMahon, C. G. (1998) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900344 · Cited by 68 · cited 1×
“The young man was offered an interpretation related to sexual numbing as an unconscious wish to protect himself from rejection, a rejection having been the trigger for the long-resolved depressive symptoms.”
BackgroundAntidepressant drug side effects.
Cole, J. O., & Bodkin, J. A. (1990) · PubMed · Cited by 54
Arafa, M. M., & Shamloul, R. M. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901469 · Cited by 48 · cited 8×
“Csoka, Bahrick, and Mehtonen [8] report three more similar cases.”
BackgroundMethodInfluentialRaap, D. K., Garcia, F., Muma, N. A., Wolf, W. A., Battaglia, G., & van de Kar, L. D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37990-x · Cited by 46 · cited 1×
“However, post SSRI persistence of biological changes or adaptations can by no means be ruled out [8], are supported by animal studies [50-52], and thus ought to be a cause for concern.”
BackgroundPharmacological treatment of premature ejaculation
McMahon, C. G., & Samali, R. (1999) · Current Opinion in Urology · doi:10.1097/00042307-199911000-00011 · Cited by 46 · cited 1×
“The well-established ejaculation-delaying effects of all of the SSRIs has led to their ubiquitous off-label use as a treatment for premature ejaculation (PE), and motivated industry to seek approval of SSRIs for a new indication reported to affect approximately 30% of men globally across all age groups [44] and to aff…”
BackgroundUrologist Practice Patterns in the Management of Premature Ejaculation: A Nationwide Survey
Shindel, A. W., Nelson, C. J., & Brandes, S. B. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00638.x · Cited by 45 · cited 1×
“…sexual dysfunctions at baseline, Montejo et al. [14] found citalopram or sertraline-treated patients reported, respectively, 62.1% and 54.7% treatment-emergent decreased desire; 63.3% and 56.6% delayed orgasm or ejaculation; and 34.8% and 28.9% erectile dysfunction or decreased vaginal lubrication.”
BackgroundInfluentialGenital Anaesthesia Persisting Six Years after Sertraline Discontinuation
Bolton, J. M., Sareen, J., & Reiss, J. P. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600666410 · Cited by 45
Reisman, Y. (2020) · BMJ · doi:10.1136/bmj.m754 · Cited by 44
Montejo-Gonzalez, Llorca, Izquierdo, M., & Ledesma (1997) · Journal of Sex & Marital Therapy · Cited by 44
Current and Future Pharmacotherapies of Premature Ejaculation
Hellstrom, W. J. G. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00309.x · Cited by 40 · cited 1×
“The patient maintained the conviction that his symptoms were a result of his past medication use, and declined the offer of a course of psychodynamic psychotherapy.”
BackgroundIatrogenic sexual dysfunction and the protective withholding of information: in whose best interest?
Higgins, A., Barker, P., & Begley, C. (2006) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2006.01001.x · Cited by 39
Penile anesthesia associated with fluoxetine use
Neill, J. R. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1603b · Cited by 39
Selective Serotonin Reuptake Inhibitor–Induced Sexual Dysfunction in Adolescents: A Review
Scharko, A. M. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000131135.70992.58 · Cited by 36 · cited 1×
“In addition, two distinctive sexual symptoms are highlighted that are rarely reported in the research literature, but are often identified as among those symptoms that persist after treatment discontinuation in both case reports and among members of an Internet community.”
BackgroundPerspectives on the Efficacy of Antidepressants for Child and Adolescent Depression
Raz, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030009 · Cited by 31 · cited 1×
“taken an SSRI or SNRI over the last ten years [3].”
BackgroundSSRI-Associated Sexual Dysfunction
Balon, R. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1504 · Cited by 29
Fluoxetine-Induced Genital Anesthesia Relieved by Ginkgo biloba Extract
Ellison, J. M., & DeLuca, P. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0409f · Cited by 26 · cited 1×
“The 2-16% pre-market rates of SSRI and SNRI-induced sexual side effects are based on spontaneous reports of individuals in initial trials who had been on the medications a short time.”
BackgroundManagement of and Counseling for Psychotropic Drug‐Induced Sexual Dysfunction
Gutierrez, M. A., & Stimmel, G. L. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.10.823.31553 · Cited by 22
Vaginal anesthesia associated with fluoxetine use
King, V. L., & Horowitz, I. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.984b · Cited by 22
Penile anesthesia and fluoxetine
Measom, M. O. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.5.709a · Cited by 21 · cited 1×
“The 2-16% pre-market rates of SSRI and SNRI-induced sexual side effects are based on spontaneous reports of individuals in initial trials who had been on the medications a short time.”
BackgroundKauffman, R. P., & Murdock, A. (2007) · The Open Women's Health Journal · doi:10.2174/1874291200701010001 · Cited by 19 · cited 3×
“info/forum/], and described in a series of recent case reports [6-9].”
BackgroundInfluentialMontejo, A. L., Llorca, G., Izquierdo, J. A., Carrasco, J. L., Daniel, E., Pérez-Sola, V., Vicens, E., Bousoño, M., Sánchez-Iglesias, S., Franco, M., et al. (1999) · PubMed · Cited by 18
Postmarketing surveillance—lack of vigilance, lack of trust
Fontanarosa, P., Rennie, D., & DeAngelis, C. D. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.04.002 · Cited by 18
Is psychologists' involvement in the prescribing of psychotropic medication really a new activity?
VandenBos, G. R., & Williams, S. (2000) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.31.6.615 · Cited by 17
Must all psychologists study psychopharmacology?
Barnett, J. E., & Neel, M. L. (2000) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.31.6.619 · Cited by 16
Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats.
Seftel, A. D. (2003) · PubMed · Cited by 15
Penile Anesthesia Associated With Sertraline Use
Deisenhammer, E., & Trawöger, R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1218 · Cited by 13 · cited 3×
“The 2-16% pre-market rates of SSRI and SNRI-induced sexual side effects are based on spontaneous reports of individuals in initial trials who had been on the medications a short time.”
BackgroundSexual Function and Dysfunction During Treatment With Psychotropic Medications
Balon, R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1120 · Cited by 11
The Modified Rush Sexual Inventory: Preliminary psychometric findings
Rao, D., Zajecka, J., & Skubiak, T. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.05.007 · Cited by 10 · cited 1×
“The man, reported not to have any preexisting sexual dysfunctions, experienced penile anesthesia after three days on the medication.”
BackgroundSexual dysfunction associated with antidepressant treatment.
Rivas-Vazquez, R. A., Blais, M. A., Rey, G. J. F. D., & Rivas-Vazquez, A. A. (2000) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.31.6.641 · Cited by 9 · cited 3×
“[5], sorting out the etiology of sexual dysfunction can be challenging.”
BackgroundInfluentialAntidepressant-associated changes in semen parameters
Tanrikut, C., Feldman, A. S., Altemus, M. M., Paduch, D. A., & Schlegel, P. N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.07.287 · Cited by 6
McMahon, C. G. (1998) · The Journal of Urology · doi:10.1097/00005392-199806000-00044 · Cited by 4
Psychopharmacologic Treatment of Depression in Men
Cochran, S. V., & Rabinowitz, F. E. (2000) · Elsevier eBooks · doi:10.1016/b978-012177540-7/50006-0 · Cited by 2
Kauffman, R. P., & Murdock, A. (2007) · The Open Women s Health Journal · doi:10.2174/187429120701011021 · Cited by 1
Research works printed but not linked: 3
- [32]32. Michael A, Mayer, C. Fluoxetine-induced anesthesia of vagina and nipples [Letter to the Editor]. Br J Psychiat 2000; 176: 984-985.
- [53]53. Montejo A L, Majadas, S. Sexual disturbances associated with antidepressant treatments. World Psychiatric Association Bulletin on Depression 2004; 9: 28.
- [55]55. Sussman N. Side effects of psychotropic medications: Importance of postmarketing surveillance. Prim Psychiat 2007; 14: 14-15.
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Post-SSRI Sexual Dysfunction: A Literature Review
Bala, A., Nguyen, H. M. T., & Hellstrom, W. J. G. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.07.002 · Cited by 167
Singh, K., Pal, R., Khan, S. A., Kumar, B., & Akhtar, M. J. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130369 · Cited by 132
Reconsidering Asexuality and Its Radical Potential
Chasin, C. D. (2013) · Feminist Studies · doi:10.1353/fem.2013.0054 · Cited by 109
American psychiatry in the new millennium: a critical appraisal
Scull, A. T. (2021) · Psychological Medicine · doi:10.1017/s0033291721001975 · Cited by 100
“Bahrick, A. S. (2008). Persistence of sexual dysfunction side effects after dis-”
Background
Metadata
- Authors
- Bahrick, A. S.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Bahrick, Audrey S.
- Venue
- The Open Psychology Journal
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-05-05
- Volume
- 1
- Issue
- 1
- Pages
- 42-50
- ISSN
- 1874-3501 (ISSN-L)
- OpenAlex
- W2127932170
- Semantic Scholar
- a6c2453868b92651a0ebdb91efabaf6f05ccba07
- Cited by
- 41
- References
- 61
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2021: 7 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Open Psychology Journal (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- sexual dysfunction, antidepressant side effects, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, premature ejaculation, informed consent
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.